All stocks Β· VIVIMEDLAB
VL

Vivimed Labs Ltd.

VIVIMEDLAB BSE Drug Manufacturers - Specialty & Generic Healthcare

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It oper…

ISIN INE526G01021
Listed β€”
Quarters tracked 13
Filings 20 docs

About

Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.

Key Metrics

as of Sep 2026
Market Cap55 Cr
P/Eβ€”
Div Yield0.00 %
Book Valueβ‚Ή-25.40
52w Highβ‚Ή29.40
52w Lowβ‚Ή4.75
Face Valueβ‚Ή2.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023
Sales 8.00 12.00 19.00 18.00 23.00 34.00 22.00 25.00 36.00 37.00 30.00 33.00 40.00
Expenses 145.00 23.00 20.00 18.00 25.00 34.00 23.00 36.00 65.00 36.00 36.00 33.00 203.00
Operating Profit -137.00 -11.00 -1.00 -1.00 -2.00 0.00 -1.00 -11.00 -29.00 1.00 -5.00 0.00 -164.00
OPM % -1,815.00 -96.00 -7.00 -3.00 -11.00 -0.50 -3.60 -45.00 -79.00 2.40 -18.00 -0.90 -412.00
Other Income 0.00 0.00 0.00 0.00 4.00 0.00 0.00 0.00 7.00 0.00 2.00 0.00 0.00
Depreciation 4.00 4.00 5.00 5.00 5.00 6.00 4.00 4.00 5.00 4.00 4.00 4.00 95.00
Interest 1.00 1.00 2.00 1.00 1.00 0.00 0.00 0.00 -34.00 13.00 12.00 11.00 8.00
Profit before tax -142.00 -17.00 -7.00 -6.00 -4.00 -7.00 -5.00 -15.00 7.00 -17.00 -20.00 -15.00 -267.00
Tax % 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 24.00 -3.00 0.00 0.00 -1.00
Net Profit -142.00 -17.00 -7.00 -6.00 -4.00 -7.00 -5.00 -15.00 6.00 -16.00 -20.00 -15.00 -265.00
EPS in Rs -17.14 -2.00 -0.90 -0.66 -0.53 -0.84 -0.60 -1.82 0.66 -1.95 -2.36 -1.85 -31.94

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 56.00104.00137.00177.00218.00210.00277.00252.00261.00570.00319.00430.00
Expenses 206.00118.00170.00365.00227.00182.00237.00184.00183.00319.00233.00323.00
Operating Profit -150.00-15.00-33.00-188.00-9.0028.0040.0067.0078.00250.0086.00107.00
OPM % -269.00-14.00-24.00-106.00-4.1013.0014.0027.0030.0044.0027.0025.00
Other Income 1.004.0010.000.001.006.000.009.002.009.001.001.00
Interest 4.003.002.0036.0040.0042.0043.0053.0053.0059.0057.0064.00
Depreciation 18.0019.0018.00107.0017.0016.0017.0018.0018.0027.0019.0021.00
Profit before tax -172.00-32.00-44.00-330.00-65.00-24.00-21.005.009.00173.0011.0024.00
Tax % 0.000.000.00-1.004.00-1.00-8.00-20.00-12.0027.0028.0022.00
Net Profit -172.00-32.00-44.00-328.00-68.00-23.00-19.006.0010.00126.008.0019.00
EPS in Rs -20.70-3.80-5.35-39.56-8.17-2.81-2.310.751.2015.591.002.34
Dividend Payout % 0.000.000.000.000.000.000.000.0033.003.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 17.0017.0017.0017.0017.0017.0017.0017.0017.0016.0016.0016.00
Reserves -129.0042.0073.00117.00441.00508.00537.00556.00551.00545.00353.00358.00
Borrowings 388.00375.00375.00377.00357.00323.00304.00348.00446.00571.00599.00698.00
Other Liabilities 226.00206.00217.00286.00258.00247.00210.00234.00243.00229.00397.00231.00
Total Liabilities 502.00639.00681.00796.001,072.001,095.001,067.001,155.001,255.001,361.001,365.001,303.00
Fixed Assets 286.00315.00326.00343.00429.00416.00356.00381.00405.00433.00387.00377.00
CWIP 17.0017.0021.0021.0040.0058.0070.0064.0043.0059.0041.0063.00
Investments 56.0059.0059.00161.00161.00161.0088.0088.00152.0088.00230.00230.00
Other Assets 142.00248.00276.00271.00442.00459.00554.00622.00656.00781.00708.00633.00
Total Assets 502.00639.00681.00796.001,072.001,095.001,067.001,155.001,255.001,361.001,365.001,303.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 4.006.00-97.0033.0025.00180.0075.0082.00207.0028.00-54.0041.00
Cash from Investing Activity 0.00-4.00100.00-2.00-11.00-138.003.0056.00-38.0030.00-11.00-50.00
Cash from Financing Activity -5.00-3.00-6.00-35.00-13.00-46.00-91.00-123.00-175.00-50.0059.009.00
Net Cash Flow 0.00-1.00-2.00-3.001.00-5.00-13.0015.00-6.008.00-7.001.00
Free Cash Flow 4.002.00-99.0031.0014.00115.0078.0066.00232.0053.00-65.00-6.00
CFO/OP % -3.00-39.00291.00-17.00-280.00654.00205.00160.00285.0016.00-63.0039.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 284.00161.00159.00104.00106.00133.00118.00148.00234.00144.00264.00194.00
Inventory Days 56.00354.00340.00106.00608.00954.00640.001,284.001,236.00579.00744.00410.00
Days Payable 266.00211.00211.0077.0095.00124.0075.00160.0099.0092.0068.0084.00
Cash Conversion Cycle 73.00304.00289.00134.00619.00963.00683.001,271.001,371.00632.00940.00520.00
Working Capital Days -1,828.00-513.00-311.00-299.00116.00213.00319.00375.00345.00168.00291.00132.00
ROCE % -47.00-6.00-9.00-44.00-3.002.003.006.006.0022.007.008.00

Shareholding Pattern

% holding β€” latest first
Holder Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 7.57 7.76 7.76 7.76 20.94 20.94 20.94 20.94 20.94 20.94 20.94 20.94
FIIs 1.64 1.64 1.64 1.64 1.64 1.64 1.64 1.64 1.64 1.64 1.64 1.64
Public 90.66 90.47 90.47 90.47 77.30 77.30 77.30 77.30 77.29 77.30 77.29 77.30
No. of Shareholders 47,492 49,221 48,925 48,928 48,957 49,005 49,003 49,012 49,016 49,027 49,038 49,503

Corporate Actions

21 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Other 27 Dec 2024 β€” β€” β€” Annual General Meeting
Other 07 Nov 2023 β€” β€” β€” Annual General Meeting
Other 21 Mar 2023 β€” β€” β€” Annual General Meeting
Other 10 Feb 2023 β€” β€” β€” Annual General Meeting
Other 23 Dec 2020 β€” β€” β€” Annual General Meeting
Other 23 Sep 2019 β€” β€” β€” Annual General Meeting
Dividend 19 Sep 2018 β€” β€” 0.40
Dividend 21 Sep 2017 β€” β€” 0.40
Other 22 Sep 2016 β€” β€” β€” Annual General Meeting
Split 06 Apr 2016 08 Apr 2016 10:2 β€”
Other 23 Sep 2015 β€” β€” β€” Annual General Meeting
Dividend 24 Sep 2014 β€” β€” 3.00
Dividend 24 Sep 2013 β€” β€” 3.00
Dividend 21 Sep 2012 β€” β€” 3.00
Dividend 26 Sep 2011 β€” β€” 2.00
Dividend 09 Sep 2010 β€” β€” 1.50
Dividend 24 Sep 2009 β€” β€” 1.50
Dividend 22 Sep 2008 β€” β€” 1.00 NSE/BSE dividend mismatch: NSE=0.2; BSE=1.0
Dividend 22 Sep 2008 β€” β€” 0.20 NSE/BSE dividend mismatch: NSE=0.2; BSE=1.0
Other 20 Dec 2007 β€” β€” β€” Annual General Meeting
Other 21 Sep 2006 β€” β€” β€” Agm

Announcements

5 filings